4//SEC Filing
Manzo Louis 4
Accession 0001415889-22-003580
CIK 0001133869other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:00 PM ET
Size
11.9 KB
Accession
0001415889-22-003580
Insider Transaction Report
Form 4
Manzo Louis
Director
Transactions
- Tax Payment
Common Stock
2022-03-31$3.43/sh−11,309$38,790→ 16,595 total - Exercise/Conversion
Common Stock
2022-03-31$1.39/sh+27,904$38,787→ 27,904 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-31−15,455→ 0 totalExercise: $1.39Exp: 2022-04-27→ Common Stock (15,455 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-31−12,449→ 0 totalExercise: $1.39Exp: 2022-04-27→ Common Stock (12,449 underlying)
Footnotes (5)
- [F1]Represents a "net exercise" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on March 31, 2022 of $3.43. The options would otherwise expire on April 27, 2022, pursuant to their terms.
- [F2]This option was granted on April 27, 2012 and was previously reported as covering 154,555 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F3]The shares vested 1/48th of the first day of each month, commencing May 1, 2012.
- [F4]This option was granted on April 27, 2012 and was previously reported as covering 124,491 shares at an exercise price of $0.37 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice to $1.39 per share that occurred on February 12, 2020.
- [F5]The shares vested immediately.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001593100
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 5:00 PM ET
- Size
- 11.9 KB